Dr. Maria Scalley, PSY.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 76 Park Ave, Freeport, NY 11520 Phone: 516-377-0194 |
Dr. Edward Elsworth Stevenson Jr., PH. D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 137 Putnam Ave, Freeport, NY 11520 Phone: 516-868-2583 Fax: 516-868-6253 |
Ms. June L Owen, PSYD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 932 South Long Beach Avenue, Freeport, NY 11520 Phone: 516-868-1426 Fax: 516-868-1426 |
Elizabeth Yissel Reyesboubert, SCHOOL PSYCHOLOGIST Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 118 Saint Marks Ave, Freeport, NY 11520 Phone: 516-643-4026 |
Samantha Edwards Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 6 Delisle Avenue, Freeport, NY 11520 Phone: 516-378-0670 |
News Archive
In a significant step toward growing replacement kidneys, researchers at the University of Virginia School of Medicine have identified the cells that give rise to the blood vessels within the kidney. It's a discovery of critical importance, as efforts to grow kidneys have long been frustrated by the inability to create the vasculature necessary for a functional organ.
Avisio, Inc. announces the signing of a definitive agreement to commercialize Instant Detect, a portable nano-based diagnostic technology. Avisio, a publicly-traded commercialization company with a mission to unlock the value of high-potential assets and transform them into high-value businesses, now has the worldwide license to commercialize Instant Detect's ground-breaking portable diagnostic sensory technology.
When investigating cancer cells, researchers discovered numerous peculiarities: Particular RNA molecules are present in large numbers, particular genes are overactive. Do these characteristics have a relation to cancer? Do they promote cell growth? Do they inactivate growth brakes or are they just a whim of nature?
Neurotrope, Inc. (OTCQB: NTRP) today announced that results from a new study, entitled, "PKCe Deficits in Alzheimer's Disease Brains and Skin Fibroblasts," published in the recent edition of the peer-reviewed Journal of Alzheimer's Disease and co-authored by Tapan K. Khan, Ph.D.; Abhik Sen, Ph.D.; Jarin Hongpaisan, Ph.D.; Chol S. Lim, Ph.D.; Thomas J. Nelson, Ph.D., and; Dr. Daniel L. Alkon, each of the Blanchette Rockefeller Neurosciences Institute (BRNI), provide further indication of the role that protein kinase C epsilon (PKCe) may play in the potential treatment of Alzheimer's disease (AD).
› Verified 6 days ago